Stopped: The study of the long term antibody response is no longer relative due to the introduction of Covid vaccine.
The purpose of this study is to assess whether immunosuppressive therapies used by patients with chronic inflammatory rheumatic diseases have an impact on the viral load and the humoral and cellular responses during viral infection with SarSCoV2, compared to members of their family cluster infected with the same viral strain.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Detection of SarS-Cov-2 RNA in feces and nasopharyngeal swabs
Timeframe: up to Day 30
Detection of SarS-Cov-2 RNA in feces and nasopharyngeal swabs
Timeframe: between Day 30 and Day 90
Detection and quantification of IgG, IgM and IgA specific for SarS-Cov-2 N and S proteins in blood
Timeframe: up to Day 30
Detection and quantification of IgG, IgM and IgA specific for SarS-Cov-2 N and S proteins in blood
Timeframe: between Day 30 and Day 90
Detection and quantification of IgG, IgM and IgA specific for SarS-Cov-2 N and S proteins in blood
Timeframe: 6 Months
Detection and quantification of IgG, IgM and IgA specific for SarS-Cov-2 N and S proteins in blood
Timeframe: 12 Months
Detection and quantification of IgG, IgM and IgA specific for SarS-Cov-2 N and S proteins in blood
Timeframe: 24 Months
Isolation and characterization of B and T lymphocytes in blood
Timeframe: up to Day 30
Isolation and characterization of B and T lymphocytes in blood
Timeframe: between Day 30 and Day 90
Isolation and characterization of B and T lymphocytes in blood
Timeframe: 6 Months
Isolation and characterization of B and T lymphocytes in blood
Timeframe: 12 Months
Isolation and characterization of B and T lymphocytes in blood
Timeframe: 24 Months